ID   GM07343
AC   CVCL_0V38
AS   CVCL_G430
SY   GM07343A; CEPH-1341-NA07343; 1341-8346
DR   CLO; CLO_0016961
DR   Coriell; GM07343
DR   dbMHC; 48593
DR   GEO; GSM25407
DR   GEO; GSM316189
DR   GEO; GSM316190
DR   GEO; GSM316191
DR   GEO; GSM420563
DR   IHW; IHW01060
DR   IPD-IMGT/HLA; 25858
DR   Wikidata; Q54842673
RX   CelloPub=CLPUB00447;
RX   PubMed=20856902;
RX   PubMed=24924344;
WW   https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 134103.
CC   HLA typing: A*02:01,02:01; B*07:02,07:02; C*07:02,07:02; DPA1*01:03,01:03; DPB1*03:01:01,04:01; DQA1*01:02,03:01; DQB1*03:02:01,06:02; DRB1*04:04,15:01; DRB4*01 (IPD-IMGT/HLA=25858).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptome analysis by microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 05-10-23; Version: 18
//
RX   CelloPub=CLPUB00447;
RA   Mulivor R.A., Suchy S.F.;
RT   "1992/1993 catalog of cell lines. NIGMS human genetic mutant cell
RT   repository. 16th edition. October 1992.";
RL   (In) Institute for Medical Research (Camden, N.J.) NIH 92-2011; pp.1-918; National Institutes of Health; Bethesda (1992).
//
RX   PubMed=20856902; DOI=10.1371/journal.pbio.1000480;
RA   Cheung V.G., Nayak R.R., Wang I.X.-R., Elwyn S., Cousins S.M., Morley M.,
RA   Spielman R.S.;
RT   "Polymorphic cis- and trans-regulation of human gene expression.";
RL   PLoS Biol. 8:e1000480.1-e1000480.14(2010).
//
RX   PubMed=24924344; DOI=10.1186/1756-0500-7-360;
RA   Hariani G.D., Lam E.J., Havener T., Kwok P.-Y., McLeod H.L.,
RA   Wagner M.J., Motsinger-Reif A.A.;
RT   "Application of next generation sequencing to CEPH cell lines to
RT   discover variants associated with FDA approved chemotherapeutics.";
RL   BMC Res. Notes 7:360.1-360.10(2014).
//